LBA19 Pyrotinib or placebo in combination with trastuzumab and docetaxel for HER2-positive metastatic breast cancer (PHILA): A randomized phase III trial

Binghe Xu, Min Yan, F. Ma, W. Li, Quchang Ouyang, Zhong Sheng Tong, Yue Teng, S. Wang, Y. Wang, Cuizhi Geng, Tao Luo, Jin‐Cai Zhong, Q. Zhang, Q. Liu, Xiangtai Zeng, Tao Sun, Qiangan Mo, Fengqian Dong, S. Wu, Xinyu Zhu